RSS

Frost & Sullivan

R&D software provider IDBS discusses the some of the top laboratory challenges experienced by scientists. more

Opinion

Sciformix Corporation has announced that it has been awarded for best practices in Customer Service Leadership in the pharmaceutical scientific process outsourcing industry by market research company Frost & Sullivan more

News

Regenerative medicine is redefining medical technology synergies by combining stem cell technology with tissue engineering. more

News

Y. Shashidhar, partner & managing director, South Asia, Middle East & North Africa, Frost & Sullivan talks about how the local production of insulin from Novo Nordisk’s new plant in Iran could impact the pharma market more

Opinion

Frost & Sullivan is to host a webinar on stem cell therapy pipeline and treatments innovating regenerative medicine more

News

The use of small animal models in basic and preclinical research is now an integral part of developing and testing new pharmaceutical drugs prior to commercialisation. more

News

MDR-GNB (Multi-drug resistant gram-negative organisms) continue to pose a threat. New analysis finds that small firms are taking on the baton from big pharma in antibacterial drugs development. more

News

Frost & Sullivan Healthcare IT research analyst Shruthi Parakkal comments on the future implications of this acquisition. more

Frost & Sullivan's Global Regenerative Medicine Market finds approval rates and clinical activity buzz point to regenerative medicine being attractive for investors. more

News

Future revisions to in-vitro diagnostics laws will offset the launch of new tests, in a market expected to soar to $1,295.1 million in 2018. more

News